30 HALLMARK_MYOGENESIS 212 31 HALLMARK_HEME_METABOLISM 214 32 HALLMARK_GLYCOLYSIS 215 33 HALLMARK_HYPOXIA 215 34 HALLMARK_MITOTIC_SPINDLE 215 35 HALLMARK_P53_PATHWAY 215 36 HALLMARK_ESTROGEN_RESPONSE_EARLY 216 37 HALLMARK_IL2_STAT5_SIGNALING 216 38 HALLMARK_E2F_TARGETS 218 39 HALLMARK_ESTROGEN_RESPO...
37 HALLMARK_IL2_STAT5_SIGNALING 216 38 HALLMARK_E2F_TARGETS 218 39 HALLMARK_ESTROGEN_RESPONSE_LATE 218 40 HALLMARK_KRAS_SIGNALING_DN 220 41 HALLMARK_KRAS_SIGNALING_UP 220 42 HALLMARK_OXIDATIVE_PHOSPHORYLATION 220 43 HALLMARK_INFLAMMATORY_RESPONSE 222 44 HALLMARK_XENOBIOTIC_METABOLISM 224 45 HALLMARK_T...
37 HALLMARK_IL2_STAT5_SIGNALING 216 38 HALLMARK_E2F_TARGETS 218 39 HALLMARK_ESTROGEN_RESPONSE_LATE 218 40 HALLMARK_KRAS_SIGNALING_DN 220 41 HALLMARK_KRAS_SIGNALING_UP 220 42 HALLMARK_OXIDATIVE_PHOSPHORYLATION 220 43 HALLMARK_INFLAMMATORY_RESPONSE 222 44 HALLMARK_XENOBIOTIC_METABOLISM 224 45 HALLMARK_T...
30 HALLMARK_MYOGENESIS 212 31 HALLMARK_HEME_METABOLISM 214 32 HALLMARK_GLYCOLYSIS 215 33 HALLMARK_HYPOXIA 215 34 HALLMARK_MITOTIC_SPINDLE 215 35 HALLMARK_P53_PATHWAY 215 36 HALLMARK_ESTROGEN_RESPONSE_EARLY 216 37 HALLMARK_IL2_STAT5_SIGNALING 216 38 HALLMARK_E2F_TARGETS 218 39 HALLMARK_ESTROGEN_RESPO...